Rubric Capital Management LP Ars Pharmaceuticals, Inc. Comm Transaction History

Rubric Capital Management LP

  • $3.59 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
N/A
-2,160,000 Reduced 77.16%
639,203 $0
Q2 2023

Aug 11, 2023
SELL
N/A
-681,509 Reduced 19.58%
2,799,203 $0
Q1 2023

May 12, 2023
BUY
N/A
490,148 Added 16.39%
3,480,712 $0
Q4 2022

Feb 10, 2023
BUY
N/A
295,394 Added 10.96%
2,990,564 $0
Q3 2022

Nov 14, 2022
BUY
N/A
1,708,717 Added 173.22%
2,695,170 $14.2 Million
Q2 2022

Aug 15, 2022
BUY
N/A
986,453 New
986,453 $4.18 Million

About ARS PHARMACEUTICALS, INC. COMM

SPRY Quotes by TradingView
  • Ticker SPRY
More about SPRY
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email